25 XP   0   0   10

Pfizer Limited
Buy, Hold or Sell?

Let's analyse Pfizer Limited together

PenkeI guess you are interested in Pfizer Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pfizer Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pfizer Limited

I send you an email if I find something interesting about Pfizer Limited.

Quick analysis of Pfizer Limited (30 sec.)










What can you expect buying and holding a share of Pfizer Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR3.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR701.06
Expected worth in 1 year
INR1,000.91
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR559.71
Return On Investment
13.3%

For what price can you sell your share?

Current Price per Share
INR4,194.95
Expected price per share
INR4,040 - INR4,695
How sure are you?
50%

1. Valuation of Pfizer Limited (5 min.)




Live pricePrice per Share (EOD)

INR4,194.95

Intrinsic Value Per Share

INR409.87 - INR1,134.34

Total Value Per Share

INR1,110.93 - INR1,835.40

2. Growth of Pfizer Limited (5 min.)




Is Pfizer Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$384.8m$343.7m$41.1m10.7%

How much money is Pfizer Limited making?

Current yearPrevious yearGrowGrow %
Making money$74.8m$73.5m$1.3m1.8%
Net Profit Margin25.7%23.5%--

How much money comes from the company's main activities?

3. Financial Health of Pfizer Limited (5 min.)




What can you expect buying and holding a share of Pfizer Limited? (5 min.)

Welcome investor! Pfizer Limited's management wants to use your money to grow the business. In return you get a share of Pfizer Limited.

What can you expect buying and holding a share of Pfizer Limited?

First you should know what it really means to hold a share of Pfizer Limited. And how you can make/lose money.

Speculation

The Price per Share of Pfizer Limited is INR4,195. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pfizer Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pfizer Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR701.06. Based on the TTM, the Book Value Change Per Share is INR74.96 per quarter. Based on the YOY, the Book Value Change Per Share is INR103.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR64.96 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pfizer Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps1.640.0%1.640.0%1.610.0%1.400.0%1.040.0%
Usd Book Value Change Per Share0.900.0%0.900.0%1.240.0%0.270.0%0.400.0%
Usd Dividend Per Share0.780.0%0.780.0%0.420.0%1.140.0%0.930.0%
Usd Total Gains Per Share1.680.0%1.680.0%1.660.0%1.410.0%1.330.0%
Usd Price Per Share41.61-41.61-52.18-47.25-34.90-
Price to Earnings Ratio25.42-25.42-32.48-34.22-42.43-
Price-to-Total Gains Ratio24.78-24.78-31.52-34.09-31.86-
Price to Book Ratio4.95-4.95-6.94-6.20-5.63-
Price-to-Total Gains Ratio24.78-24.78-31.52-34.09-31.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share50.3394
Number of shares19
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.781.14
Usd Book Value Change Per Share0.900.27
Usd Total Gains Per Share1.681.41
Gains per Quarter (19 shares)31.9026.86
Gains per Year (19 shares)127.61107.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15968118872197
211813724617342204
317820537426063311
423727350234684418
5296342630433104525
6355410758519125632
7415479886606146739
84745471014692167846
95336151142779188953
1059268412708652091060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%8.02.00.080.0%16.02.00.088.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.01.094.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%

Fundamentals of Pfizer Limited

About Pfizer Limited

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-03-12 07:40:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is overpriced.

1.1. Profitability of Pfizer Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pfizer Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 25.7% means that ₹0.26 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pfizer Limited:

  • The MRQ is 25.7%. The company is making a huge profit. +2
  • The TTM is 25.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ25.7%TTM25.7%0.0%
TTM25.7%YOY23.5%+2.3%
TTM25.7%5Y23.1%+2.6%
5Y23.1%10Y18.8%+4.3%
1.1.2. Return on Assets

Shows how efficient Pfizer Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • 15.6% Return on Assets means that Pfizer Limited generated ₹0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pfizer Limited:

  • The MRQ is 15.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.6%TTM15.6%0.0%
TTM15.6%YOY15.7%-0.1%
TTM15.6%5Y13.8%+1.8%
5Y13.8%10Y12.3%+1.5%
1.1.3. Return on Equity

Shows how efficient Pfizer Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • 19.5% Return on Equity means Pfizer Limited generated ₹0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pfizer Limited:

  • The MRQ is 19.5%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.5%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.5%TTM19.5%0.0%
TTM19.5%YOY21.4%-1.9%
TTM19.5%5Y18.2%+1.3%
5Y18.2%10Y16.6%+1.6%

1.2. Operating Efficiency of Pfizer Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pfizer Limited is operating .

  • Measures how much profit Pfizer Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 33.2% means the company generated ₹0.33  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pfizer Limited:

  • The MRQ is 33.2%. The company is operating very efficient. +2
  • The TTM is 33.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ33.2%TTM33.2%0.0%
TTM33.2%YOY29.8%+3.4%
TTM33.2%5Y30.8%+2.4%
5Y30.8%10Y27.3%+3.4%
1.2.2. Operating Ratio

Measures how efficient Pfizer Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are ₹0.71 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Pfizer Limited:

  • The MRQ is 0.710. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.710. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.710TTM0.7100.000
TTM0.710YOY0.723-0.013
TTM0.7105Y0.741-0.031
5Y0.74110Y0.780-0.039

1.3. Liquidity of Pfizer Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pfizer Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 3.84 means the company has ₹3.84 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Pfizer Limited:

  • The MRQ is 3.841. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.841. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.841TTM3.8410.000
TTM3.841YOY2.810+1.031
TTM3.8415Y3.135+0.707
5Y3.13510Y2.780+0.355
1.3.2. Quick Ratio

Measures if Pfizer Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 5.95 means the company can pay off ₹5.95 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pfizer Limited:

  • The MRQ is 5.951. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.951. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.951TTM5.9510.000
TTM5.951YOY4.096+1.855
TTM5.9515Y4.186+1.765
5Y4.18610Y3.368+0.818

1.4. Solvency of Pfizer Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pfizer Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pfizer Limited to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.20 means that Pfizer Limited assets are financed with 19.8% credit (debt) and the remaining percentage (100% - 19.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pfizer Limited:

  • The MRQ is 0.198. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.198. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.198TTM0.1980.000
TTM0.198YOY0.266-0.067
TTM0.1985Y0.239-0.041
5Y0.23910Y0.253-0.014
1.4.2. Debt to Equity Ratio

Measures if Pfizer Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 24.7% means that company has ₹0.25 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pfizer Limited:

  • The MRQ is 0.247. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.247. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.247TTM0.2470.000
TTM0.247YOY0.362-0.114
TTM0.2475Y0.316-0.069
5Y0.31610Y0.341-0.025

2. Market Valuation of Pfizer Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Pfizer Limited generates.

  • Above 15 is considered overpriced but always compare Pfizer Limited to the Drug Manufacturers - General industry mean.
  • A PE ratio of 25.42 means the investor is paying ₹25.42 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pfizer Limited:

  • The EOD is 30.759. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.423. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.423. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD30.759MRQ25.423+5.337
MRQ25.423TTM25.4230.000
TTM25.423YOY32.475-7.052
TTM25.4235Y34.223-8.801
5Y34.22310Y42.430-8.207
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pfizer Limited:

  • The EOD is 66.019. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 54.565. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 54.565. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD66.019MRQ54.565+11.454
MRQ54.565TTM54.5650.000
TTM54.565YOY30.521+24.043
TTM54.5655Y71.755-17.190
5Y71.75510Y61.358+10.396
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pfizer Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 4.95 means the investor is paying ₹4.95 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Pfizer Limited:

  • The EOD is 5.984. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.946. Based on the equity, the company is fair priced.
  • The TTM is 4.946. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD5.984MRQ4.946+1.038
MRQ4.946TTM4.9460.000
TTM4.946YOY6.945-1.999
TTM4.9465Y6.203-1.257
5Y6.20310Y5.625+0.578
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pfizer Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--74.96374.9630%103.031-27%22.914+227%33.067+127%
Book Value Per Share--701.059701.0590%626.095+12%650.121+8%540.398+30%
Current Ratio--3.8413.8410%2.810+37%3.135+23%2.780+38%
Debt To Asset Ratio--0.1980.1980%0.266-25%0.239-17%0.253-22%
Debt To Equity Ratio--0.2470.2470%0.362-32%0.316-22%0.341-27%
Dividend Per Share--64.96564.9650%34.916+86%94.875-32%77.452-16%
Eps--136.380136.3800%133.892+2%116.821+17%86.662+57%
Free Cash Flow Per Share--63.54263.5420%142.462-55%76.577-17%61.390+4%
Free Cash Flow To Equity Per Share---12.042-12.0420%103.007-112%-27.061+125%-25.761+114%
Gross Profit Margin--0.9010.9010%0.758+19%0.778+16%0.685+32%
Intrinsic Value_10Y_max--1134.343--------
Intrinsic Value_10Y_min--409.868--------
Intrinsic Value_1Y_max--102.010--------
Intrinsic Value_1Y_min--56.844--------
Intrinsic Value_3Y_max--315.384--------
Intrinsic Value_3Y_min--158.144--------
Intrinsic Value_5Y_max--539.474--------
Intrinsic Value_5Y_min--244.805--------
Market Cap191909314115.000+17%158619952465.550158619952465.5500%198929480011.800-20%180156954913.630-12%133069150002.775+19%
Net Profit Margin--0.2570.2570%0.235+10%0.231+11%0.188+37%
Operating Margin--0.3320.3320%0.298+11%0.308+8%0.273+21%
Operating Ratio--0.7100.7100%0.723-2%0.741-4%0.780-9%
Pb Ratio5.984+17%4.9464.9460%6.945-29%6.203-20%5.625-12%
Pe Ratio30.759+17%25.42325.4230%32.475-22%34.223-26%42.430-40%
Price Per Share4194.950+17%3467.1503467.1500%4348.150-20%3937.840-12%2908.630+19%
Price To Free Cash Flow Ratio66.019+17%54.56554.5650%30.521+79%71.755-24%61.358-11%
Price To Total Gains Ratio29.979+17%24.77824.7780%31.521-21%34.087-27%31.857-22%
Quick Ratio--5.9515.9510%4.096+45%4.186+42%3.368+77%
Return On Assets--0.1560.1560%0.157-1%0.138+13%0.123+27%
Return On Equity--0.1950.1950%0.214-9%0.182+7%0.166+17%
Total Gains Per Share--139.928139.9280%137.946+1%117.789+19%110.519+27%
Usd Book Value--384876000.000384876000.0000%343729200.000+12%356917920.000+8%296676944.400+30%
Usd Book Value Change Per Share--0.9000.9000%1.236-27%0.275+227%0.397+127%
Usd Book Value Per Share--8.4138.4130%7.513+12%7.801+8%6.485+30%
Usd Dividend Per Share--0.7800.7800%0.419+86%1.139-32%0.929-16%
Usd Eps--1.6371.6370%1.607+2%1.402+17%1.040+57%
Usd Free Cash Flow--34884000.00034884000.0000%78212400.000-55%42041040.000-17%33702961.200+4%
Usd Free Cash Flow Per Share--0.7630.7630%1.710-55%0.919-17%0.737+4%
Usd Free Cash Flow To Equity Per Share---0.145-0.1450%1.236-112%-0.325+125%-0.309+114%
Usd Market Cap2302911769.380+17%1903439429.5871903439429.5870%2387153760.142-20%2161883458.964-12%1596829800.033+19%
Usd Price Per Share50.339+17%41.60641.6060%52.178-20%47.254-12%34.904+19%
Usd Profit--74871600.00074871600.0000%73507200.000+2%64134720.000+17%46590999.600+61%
Usd Revenue--290971200.000290971200.0000%313266000.000-7%276160080.000+5%243218385.600+20%
Usd Total Gains Per Share--1.6791.6790%1.655+1%1.413+19%1.326+27%
 EOD+4 -4MRQTTM+0 -0YOY+21 -155Y+27 -910Y+32 -4

3.2. Fundamental Score

Let's check the fundamental score of Pfizer Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.759
Price to Book Ratio (EOD)Between0-15.984
Net Profit Margin (MRQ)Greater than00.257
Operating Margin (MRQ)Greater than00.332
Quick Ratio (MRQ)Greater than15.951
Current Ratio (MRQ)Greater than13.841
Debt to Asset Ratio (MRQ)Less than10.198
Debt to Equity Ratio (MRQ)Less than10.247
Return on Equity (MRQ)Greater than0.150.195
Return on Assets (MRQ)Greater than0.050.156
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Pfizer Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.767
Ma 20Greater thanMa 504,398.063
Ma 50Greater thanMa 1004,418.619
Ma 100Greater thanMa 2004,280.116
OpenGreater thanClose4,380.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets40,007,300
Total Liabilities7,934,300
Total Stockholder Equity32,073,000
 As reported
Total Liabilities 7,934,300
Total Stockholder Equity+ 32,073,000
Total Assets = 40,007,300

Assets

Total Assets40,007,300
Total Current Assets25,250,900
Long-term Assets14,756,400
Total Current Assets
Cash And Cash Equivalents 366,000
Short-term Investments 18,458,700
Net Receivables 1,834,800
Inventory 4,177,000
Other Current Assets 414,400
Total Current Assets  (as reported)25,250,900
Total Current Assets  (calculated)25,250,900
+/-0
Long-term Assets
Property Plant Equipment 1,854,600
Goodwill 5,274,900
Intangible Assets 442,300
Long-term Assets Other 6,207,900
Long-term Assets  (as reported)14,756,400
Long-term Assets  (calculated)13,779,700
+/- 976,700

Liabilities & Shareholders' Equity

Total Current Liabilities6,573,500
Long-term Liabilities1,360,800
Total Stockholder Equity32,073,000
Total Current Liabilities
Short-term Debt 411,500
Short Long Term Debt 25,000
Accounts payable 2,170,600
Other Current Liabilities 3,956,600
Total Current Liabilities  (as reported)6,573,500
Total Current Liabilities  (calculated)6,563,700
+/- 9,800
Long-term Liabilities
Long term Debt Total 933,200
Long-term Liabilities  (as reported)1,360,800
Long-term Liabilities  (calculated)933,200
+/- 427,600
Total Stockholder Equity
Common Stock457,500
Retained Earnings 14,600,500
Accumulated Other Comprehensive Income 3,808,300
Capital Surplus 13,206,700
Total Stockholder Equity (as reported)32,073,000
Total Stockholder Equity (calculated)32,073,000
+/- 0
Other
Capital Stock457,500
Cash And Equivalents287,000
Cash and Short Term Investments 18,824,700
Common Stock Shares Outstanding 45,749
Current Deferred Revenue34,800
Liabilities and Stockholders Equity 40,007,300
Net Debt 978,700
Net Invested Capital 32,098,000
Net Working Capital 18,677,400
Property Plant and Equipment Gross 1,854,600
Short Long Term Debt Total 1,344,700



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-31
> Total Assets 
5,221,745
5,760,631
6,465,075
8,674,618
10,976,390
12,033,690
13,862,525
15,764,549
20,595,001
9,243,473
26,115,472
29,137,080
32,706,269
36,899,600
39,399,900
44,054,000
32,659,000
39,005,100
40,007,300
40,007,30039,005,10032,659,00044,054,00039,399,90036,899,60032,706,26929,137,08026,115,4729,243,47320,595,00115,764,54913,862,52512,033,69010,976,3908,674,6186,465,0755,760,6315,221,745
   > Total Current Assets 
3,801,020
4,526,239
5,472,492
7,806,429
9,914,056
10,820,796
11,715,134
13,308,023
18,043,865
6,852,279
12,532,839
16,298,454
20,788,862
24,167,200
27,166,700
30,482,500
19,247,100
23,964,800
25,250,900
25,250,90023,964,80019,247,10030,482,50027,166,70024,167,20020,788,86216,298,45412,532,8396,852,27918,043,86513,308,02311,715,13410,820,7969,914,0567,806,4295,472,4924,526,2393,801,020
       Cash And Cash Equivalents 
1,613,872
2,101,503
3,069,443
4,799,126
5,436,483
5,274,045
5,739,862
8,620,432
14,285,572
2,932,430
5,939,822
10,024,006
675,854
507,300
738,100
17,637,900
1,570,300
627,600
366,000
366,000627,6001,570,30017,637,900738,100507,300675,85410,024,0065,939,8222,932,43014,285,5728,620,4325,739,8625,274,0455,436,4834,799,1263,069,4432,101,5031,613,872
       Short-term Investments 
699,092
660,822
666,731
0
2,479,648
3,720,916
0
500
0
0
0
43,257
14,320,000
17,211,300
18,180,000
4,310,000
9,410,000
15,472,900
18,458,700
18,458,70015,472,9009,410,0004,310,00018,180,00017,211,30014,320,00043,25700050003,720,9162,479,6480666,731660,822699,092
       Net Receivables 
0
0
0
0
0
0
0
0
0
2,069,671
2,078,994
1,422,978
1,558,400
3,081,000
3,494,600
3,306,900
2,424,700
3,358,200
1,834,800
1,834,8003,358,2002,424,7003,306,9003,494,6003,081,0001,558,4001,422,9782,078,9942,069,671000000000
       Inventory 
750,121
907,128
993,105
958,458
1,249,877
1,133,711
1,593,235
1,832,376
1,651,505
1,514,960
3,879,014
3,606,800
3,219,034
2,970,600
3,866,600
4,305,900
4,350,500
4,489,000
4,177,000
4,177,0004,489,0004,350,5004,305,9003,866,6002,970,6003,219,0343,606,8003,879,0141,514,9601,651,5051,832,3761,593,2351,133,7111,249,877958,458993,105907,128750,121
       Other Current Assets 
737,935
856,786
743,213
2,048,845
748,048
692,124
4,382,037
2,854,715
2,106,788
2,404,889
2,714,003
2,624,391
2,573,974
3,478,000
4,382,000
618,300
1,491,600
17,100
414,400
414,40017,1001,491,600618,3004,382,0003,478,0002,573,9742,624,3912,714,0032,404,8892,106,7882,854,7154,382,037692,124748,0482,048,845743,213856,786737,935
   > Long-term Assets 
1,420,725
1,234,392
992,583
868,189
1,062,334
1,212,894
2,147,391
2,456,526
2,551,136
2,391,194
13,582,633
12,838,626
11,917,407
12,732,400
12,233,200
13,571,500
13,411,900
15,040,300
14,756,400
14,756,40015,040,30013,411,90013,571,50012,233,20012,732,40011,917,40712,838,62613,582,6332,391,1942,551,1362,456,5262,147,3911,212,8941,062,334868,189992,5831,234,3921,420,725
       Property Plant Equipment 
756,431
777,016
715,584
704,072
830,594
932,849
366,503
313,738
252,133
231,797
876,516
1,015,973
986,072
825,400
714,300
2,152,800
1,951,400
2,200,700
1,854,600
1,854,6002,200,7001,951,4002,152,800714,300825,400986,0721,015,973876,516231,797252,133313,738366,503932,849830,594704,072715,584777,016756,431
       Goodwill 
0
0
0
0
0
0
0
0
0
0
5,737,549
5,310,349
5,274,860
5,274,900
5,274,900
5,274,900
5,274,900
5,274,900
5,274,900
5,274,9005,274,9005,274,9005,274,9005,274,9005,274,9005,274,8605,310,3495,737,5490000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
25
25
25
25
0
0
0
0
0
0
00000025252525000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
2,954,911
2,295,591
2,563,200
3,076,100
2,549,400
1,999,000
1,448,700
945,500
442,300
442,300945,5001,448,7001,999,0002,549,4003,076,1002,563,2002,295,5912,954,9110000000000
       Long-term Assets Other 
1,299,814
1,027,861
800,085
34,325
2,479,648
3,720,916
1,425,502
1,771,940
1,900,236
1,817,472
3,342,267
3,504,852
17,413,250
3,556,000
3,694,600
1,208,200
257,500
6,074,600
6,207,900
6,207,9006,074,600257,5001,208,2003,694,6003,556,00017,413,2503,504,8523,342,2671,817,4721,900,2361,771,9401,425,5023,720,9162,479,64834,325800,0851,027,8611,299,814
> Total Liabilities 
1,826,419
2,001,083
2,067,514
2,177,417
1,965,466
2,090,364
2,228,054
2,717,578
3,650,788
2,659,348
6,385,354
7,957,151
8,517,454
10,067,600
9,286,500
10,099,100
8,728,600
10,361,000
7,934,300
7,934,30010,361,0008,728,60010,099,1009,286,50010,067,6008,517,4547,957,1516,385,3542,659,3483,650,7882,717,5782,228,0542,090,3641,965,4662,177,4172,067,5142,001,0831,826,419
   > Total Current Liabilities 
1,706,419
2,001,083
2,067,514
2,177,417
1,965,466
2,090,364
1,882,301
2,459,293
3,509,133
2,502,842
6,063,689
7,593,686
7,869,538
9,544,400
8,916,900
8,733,600
7,743,400
8,528,900
6,573,500
6,573,5008,528,9007,743,4008,733,6008,916,9009,544,4007,869,5387,593,6866,063,6892,502,8423,509,1332,459,2931,882,3012,090,3641,965,4662,177,4172,067,5142,001,0831,706,419
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
25,022
25,022
25,000
25,000
25,000
392,500
632,300
392,500
411,500
411,500392,500632,300392,50025,00025,00025,00025,02225,0220000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
25,022
25,022
25,000
25,000
25,000
25,000
25,000
25,000
25,000
25,00025,00025,00025,00025,00025,00025,00025,02225,0220000000000
       Accounts payable 
996,094
1,199,756
1,376,204
0
1,081,757
1,162,463
17,436
20,906
8,620
15,169
20,129
30,424
32,295
106,800
4,359,200
4,267,800
2,837,400
2,639,400
2,170,600
2,170,6002,639,4002,837,4004,267,8004,359,200106,80032,29530,42420,12915,1698,62020,90617,4361,162,4631,081,75701,376,2041,199,756996,094
       Other Current Liabilities 
710,325
801,327
691,310
2,177,417
883,709
927,901
1,864,865
2,438,387
3,500,513
2,487,673
6,043,560
7,563,262
6,941,093
8,507,600
3,565,600
2,180,000
2,247,400
5,482,700
3,956,600
3,956,6005,482,7002,247,4002,180,0003,565,6008,507,6006,941,0937,563,2626,043,5602,487,6733,500,5132,438,3871,864,865927,901883,7092,177,417691,310801,327710,325
   > Long-term Liabilities 
120,000
0
0
0
0
0
345,753
258,285
141,655
156,506
321,665
363,465
647,916
523,200
369,600
1,365,500
985,200
1,832,100
1,360,800
1,360,8001,832,100985,2001,365,500369,600523,200647,916363,465321,665156,506141,655258,285345,75300000120,000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
25,022
0
0
0
886,800
426,800
1,277,400
933,200
933,2001,277,400426,800886,80000025,02200000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
148,912
296,643
636,371
624,100
523,200
369,600
478,700
558,400
554,700
0
0554,700558,400478,700369,600523,200624,100636,371296,643148,912000000000
> Total Stockholder Equity
3,395,326
3,759,548
4,397,561
6,497,201
9,010,924
9,943,326
11,634,471
13,046,971
16,944,213
6,584,125
19,730,118
21,179,929
24,188,815
26,832,000
30,113,400
33,954,900
23,930,400
28,644,100
32,073,000
32,073,00028,644,10023,930,40033,954,90030,113,40026,832,00024,188,81521,179,92919,730,1186,584,12516,944,21313,046,97111,634,4719,943,3269,010,9246,497,2014,397,5613,759,5483,395,326
   Common Stock
287,993
298,432
298,432
298,432
298,432
298,432
298,432
298,432
298,432
298,432
457,495
457,495
457,495
457,500
457,500
457,500
457,500
457,500
457,500
457,500457,500457,500457,500457,500457,500457,495457,495457,495298,432298,432298,432298,432298,432298,432298,432298,432298,432287,993
   Retained Earnings Total Equity0000000000000000000
   Accumulated Other Comprehensive Income 
-869,064
-944,301
-980,304
-812,929
-889,831
-951,669
-802,409
-848,777
-899,878
-946,509
-1,267,987
-629,249
-307,515
-445,600
-600,400
3,359,900
3,455,900
3,645,200
3,808,300
3,808,3003,645,2003,455,9003,359,900-600,400-445,600-307,515-629,249-1,267,987-946,509-899,878-848,777-802,409-951,669-889,831-812,929-980,304-944,301-869,064
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
13,206,670
13,206,700
13,206,700
13,206,700
13,206,700
13,206,700
13,206,700
13,206,700
13,206,70013,206,70013,206,70013,206,70013,206,70013,206,70013,206,70013,206,67000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
3,976,397
4,405,417
5,079,433
2,502,075
9,602,323
10,596,563
12,138,448
13,597,316
3,926,003
4,193,491
17,493,869
21,351,683
16,645,447
16,927,200
17,175,900
13,206,700
13,206,700
13,206,700
13,206,700
13,206,70013,206,70013,206,70013,206,70017,175,90016,927,20016,645,44721,351,68317,493,8694,193,4913,926,00313,597,31612,138,44810,596,5639,602,3232,502,0755,079,4334,405,4173,976,397



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue24,247,600
Cost of Revenue-8,736,700
Gross Profit15,510,90015,510,900
 
Operating Income (+$)
Gross Profit15,510,900
Operating Expense-8,477,400
Operating Income8,044,0007,033,500
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,646,600
Selling And Marketing Expenses615,900
Operating Expense8,477,4003,262,500
 
Net Interest Income (+$)
Interest Income133,900
Interest Expense-133,900
Other Finance Cost-133,900
Net Interest Income-133,900
 
Pretax Income (+$)
Operating Income8,044,000
Net Interest Income-133,900
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,240,1007,847,900
EBIT - interestExpense = 7,910,100
8,240,100
6,373,200
Interest Expense133,900
Earnings Before Interest and Taxes (EBIT)8,044,0008,374,000
Earnings Before Interest and Taxes (EBITDA)9,099,100
 
After tax Income (+$)
Income Before Tax8,240,100
Tax Provision-2,000,800
Net Income From Continuing Ops6,239,3006,239,300
Net Income6,239,300
Net Income Applicable To Common Shares6,239,300
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,214,100
Total Other Income/Expenses Net196,100133,900
 

Technical Analysis of Pfizer Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pfizer Limited. The general trend of Pfizer Limited is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pfizer Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pfizer Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4,352 < 4,680 < 4,695.

The bearish price targets are: 4,164 > 4,141 > 4,040.

Tweet this
Pfizer Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pfizer Limited. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pfizer Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pfizer Limited. The current macd is -58.55071113.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pfizer Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pfizer Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pfizer Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pfizer Limited Daily Moving Average Convergence/Divergence (MACD) ChartPfizer Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pfizer Limited. The current adx is 15.82.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Pfizer Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Pfizer Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pfizer Limited. The current sar is 3,950.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Pfizer Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pfizer Limited. The current rsi is 34.77. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Pfizer Limited Daily Relative Strength Index (RSI) ChartPfizer Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pfizer Limited. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pfizer Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pfizer Limited Daily Stochastic Oscillator ChartPfizer Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pfizer Limited. The current cci is -39.13212084.

Pfizer Limited Daily Commodity Channel Index (CCI) ChartPfizer Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pfizer Limited. The current cmo is -44.32725204.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pfizer Limited Daily Chande Momentum Oscillator (CMO) ChartPfizer Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pfizer Limited. The current willr is -76.67142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pfizer Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pfizer Limited Daily Williams %R ChartPfizer Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pfizer Limited.

Pfizer Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pfizer Limited. The current atr is 216.79.

Pfizer Limited Daily Average True Range (ATR) ChartPfizer Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pfizer Limited. The current obv is 918,892.

Pfizer Limited Daily On-Balance Volume (OBV) ChartPfizer Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pfizer Limited. The current mfi is 22.64.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pfizer Limited Daily Money Flow Index (MFI) ChartPfizer Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pfizer Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Pfizer Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pfizer Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.767
Ma 20Greater thanMa 504,398.063
Ma 50Greater thanMa 1004,418.619
Ma 100Greater thanMa 2004,280.116
OpenGreater thanClose4,380.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pfizer Limited with someone you think should read this too:
  • Are you bullish or bearish on Pfizer Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pfizer Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pfizer Limited

I send you an email if I find something interesting about Pfizer Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Pfizer Limited.

Receive notifications about Pfizer Limited in your mailbox!